P/E ratio for Adicet Bio (ACET)

P/E ratio history for Adicet Bio from 2020 to 2025

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Novartis NVS	21.6	-5,375.88%	🇨🇭 Switzerland
Pfizer PFE	19.9	-4,967.10%	🇺🇸 USA
Merck MRK	32.4	-8,016.82%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	23.8	-5,917.39%	🇮🇱 Israel
Hawkins HWKN	40.4	-9,986.60%	🇺🇸 USA
Quaker Houghton KWR	536	-131,264.09%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.